The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis.

Rezaeimanesh, Nasim; Abbasi, Naghmeh; Sahraian, Mohammad Ali; Azimi, Amirreza; Razeghi-Jahromi, Soodeh; Moghadasi, Abdorreza Naser

Rezaeimanesh, Nasim; Abbasi, Naghmeh; Sahraian, Mohammad Ali; Azimi, Amirreza; Razeghi-Jahromi, Soodeh; Moghadasi, Abdorreza Naser.

Afiliação

Rezaeimanesh N; Department of Clinical Nutrition and Dietetics, School of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abbasi N; National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sahraian MA; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azimi A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Razeghi-Jahromi S; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Moghadasi AN; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Curr J Neurol ; 22(1): 23-29, 2023 Jan 05.

Article em En | MEDLINE | ID: mdl-38011335

Palavras-chave

Body Mass Index; COVID-19; Multiple Sclerosis; Obesity; Risk; Symptom Assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr J Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google